Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Top
  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal
  • Top
  • Abstract
  • Supplemental material
  • Version history
  • Article usage
  • Citations to this article

Advertisement

ResearchIn-Press PreviewClinical ResearchGeneticsOncology Open Access | 10.1172/JCI204429

Evolution of clonal hematopoiesis during cancer treatment and its impact on outcomes

Mona Arabzadeh,1 Yi-Han Tang,2 Christelle Colin-Leitzinger,2 Sadegh Marzban,3 Daniel Walgenbach,4 Stefania Morganti,5 Vaidhyanathan Mahaganapathy,1 Erika Harper,6 Mingxiang Teng,7 Jacob K. Kresovich,2 Iman Washington,8 Heather A. Parsons,5 Judy E. Garber,5 Jeffrey West,3 Shridar Ganesan,1 Hossein Khiabanian,1 and Nancy Gillis2

1Center for Systems and Computational Biology, Rutgers Cancer Institute, Rutgers University, New Brunswick, United States of America

2Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

3Department of Integrated Mathematical Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

4Department of Internal Medicine, University of South Florida, Tampa, United States of America

5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America

6Department of Pathology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

7Department of Biostatistics and Bioinformatics, Moffitt Cancer Center and Research Institute, Tampa, United States of America

8Department of Radiation Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

Find articles by Arabzadeh, M. in: PubMed | Google Scholar

1Center for Systems and Computational Biology, Rutgers Cancer Institute, Rutgers University, New Brunswick, United States of America

2Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

3Department of Integrated Mathematical Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

4Department of Internal Medicine, University of South Florida, Tampa, United States of America

5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America

6Department of Pathology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

7Department of Biostatistics and Bioinformatics, Moffitt Cancer Center and Research Institute, Tampa, United States of America

8Department of Radiation Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

Find articles by Tang, Y. in: PubMed | Google Scholar

1Center for Systems and Computational Biology, Rutgers Cancer Institute, Rutgers University, New Brunswick, United States of America

2Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

3Department of Integrated Mathematical Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

4Department of Internal Medicine, University of South Florida, Tampa, United States of America

5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America

6Department of Pathology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

7Department of Biostatistics and Bioinformatics, Moffitt Cancer Center and Research Institute, Tampa, United States of America

8Department of Radiation Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

Find articles by Colin-Leitzinger, C. in: PubMed | Google Scholar

1Center for Systems and Computational Biology, Rutgers Cancer Institute, Rutgers University, New Brunswick, United States of America

2Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

3Department of Integrated Mathematical Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

4Department of Internal Medicine, University of South Florida, Tampa, United States of America

5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America

6Department of Pathology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

7Department of Biostatistics and Bioinformatics, Moffitt Cancer Center and Research Institute, Tampa, United States of America

8Department of Radiation Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

Find articles by Marzban, S. in: PubMed | Google Scholar

1Center for Systems and Computational Biology, Rutgers Cancer Institute, Rutgers University, New Brunswick, United States of America

2Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

3Department of Integrated Mathematical Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

4Department of Internal Medicine, University of South Florida, Tampa, United States of America

5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America

6Department of Pathology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

7Department of Biostatistics and Bioinformatics, Moffitt Cancer Center and Research Institute, Tampa, United States of America

8Department of Radiation Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

Find articles by Walgenbach, D. in: PubMed | Google Scholar

1Center for Systems and Computational Biology, Rutgers Cancer Institute, Rutgers University, New Brunswick, United States of America

2Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

3Department of Integrated Mathematical Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

4Department of Internal Medicine, University of South Florida, Tampa, United States of America

5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America

6Department of Pathology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

7Department of Biostatistics and Bioinformatics, Moffitt Cancer Center and Research Institute, Tampa, United States of America

8Department of Radiation Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

Find articles by Morganti, S. in: PubMed | Google Scholar

1Center for Systems and Computational Biology, Rutgers Cancer Institute, Rutgers University, New Brunswick, United States of America

2Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

3Department of Integrated Mathematical Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

4Department of Internal Medicine, University of South Florida, Tampa, United States of America

5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America

6Department of Pathology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

7Department of Biostatistics and Bioinformatics, Moffitt Cancer Center and Research Institute, Tampa, United States of America

8Department of Radiation Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

Find articles by Mahaganapathy, V. in: PubMed | Google Scholar

1Center for Systems and Computational Biology, Rutgers Cancer Institute, Rutgers University, New Brunswick, United States of America

2Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

3Department of Integrated Mathematical Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

4Department of Internal Medicine, University of South Florida, Tampa, United States of America

5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America

6Department of Pathology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

7Department of Biostatistics and Bioinformatics, Moffitt Cancer Center and Research Institute, Tampa, United States of America

8Department of Radiation Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

Find articles by Harper, E. in: PubMed | Google Scholar

1Center for Systems and Computational Biology, Rutgers Cancer Institute, Rutgers University, New Brunswick, United States of America

2Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

3Department of Integrated Mathematical Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

4Department of Internal Medicine, University of South Florida, Tampa, United States of America

5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America

6Department of Pathology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

7Department of Biostatistics and Bioinformatics, Moffitt Cancer Center and Research Institute, Tampa, United States of America

8Department of Radiation Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

Find articles by Teng, M. in: PubMed | Google Scholar |

1Center for Systems and Computational Biology, Rutgers Cancer Institute, Rutgers University, New Brunswick, United States of America

2Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

3Department of Integrated Mathematical Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

4Department of Internal Medicine, University of South Florida, Tampa, United States of America

5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America

6Department of Pathology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

7Department of Biostatistics and Bioinformatics, Moffitt Cancer Center and Research Institute, Tampa, United States of America

8Department of Radiation Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

Find articles by Kresovich, J. in: PubMed | Google Scholar

1Center for Systems and Computational Biology, Rutgers Cancer Institute, Rutgers University, New Brunswick, United States of America

2Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

3Department of Integrated Mathematical Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

4Department of Internal Medicine, University of South Florida, Tampa, United States of America

5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America

6Department of Pathology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

7Department of Biostatistics and Bioinformatics, Moffitt Cancer Center and Research Institute, Tampa, United States of America

8Department of Radiation Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

Find articles by Washington, I. in: PubMed | Google Scholar

1Center for Systems and Computational Biology, Rutgers Cancer Institute, Rutgers University, New Brunswick, United States of America

2Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

3Department of Integrated Mathematical Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

4Department of Internal Medicine, University of South Florida, Tampa, United States of America

5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America

6Department of Pathology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

7Department of Biostatistics and Bioinformatics, Moffitt Cancer Center and Research Institute, Tampa, United States of America

8Department of Radiation Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

Find articles by Parsons, H. in: PubMed | Google Scholar

1Center for Systems and Computational Biology, Rutgers Cancer Institute, Rutgers University, New Brunswick, United States of America

2Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

3Department of Integrated Mathematical Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

4Department of Internal Medicine, University of South Florida, Tampa, United States of America

5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America

6Department of Pathology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

7Department of Biostatistics and Bioinformatics, Moffitt Cancer Center and Research Institute, Tampa, United States of America

8Department of Radiation Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

Find articles by Garber, J. in: PubMed | Google Scholar |

1Center for Systems and Computational Biology, Rutgers Cancer Institute, Rutgers University, New Brunswick, United States of America

2Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

3Department of Integrated Mathematical Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

4Department of Internal Medicine, University of South Florida, Tampa, United States of America

5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America

6Department of Pathology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

7Department of Biostatistics and Bioinformatics, Moffitt Cancer Center and Research Institute, Tampa, United States of America

8Department of Radiation Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

Find articles by West, J. in: PubMed | Google Scholar

1Center for Systems and Computational Biology, Rutgers Cancer Institute, Rutgers University, New Brunswick, United States of America

2Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

3Department of Integrated Mathematical Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

4Department of Internal Medicine, University of South Florida, Tampa, United States of America

5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America

6Department of Pathology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

7Department of Biostatistics and Bioinformatics, Moffitt Cancer Center and Research Institute, Tampa, United States of America

8Department of Radiation Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

Find articles by Ganesan, S. in: PubMed | Google Scholar

1Center for Systems and Computational Biology, Rutgers Cancer Institute, Rutgers University, New Brunswick, United States of America

2Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

3Department of Integrated Mathematical Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

4Department of Internal Medicine, University of South Florida, Tampa, United States of America

5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America

6Department of Pathology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

7Department of Biostatistics and Bioinformatics, Moffitt Cancer Center and Research Institute, Tampa, United States of America

8Department of Radiation Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

Find articles by Khiabanian, H. in: PubMed | Google Scholar

1Center for Systems and Computational Biology, Rutgers Cancer Institute, Rutgers University, New Brunswick, United States of America

2Department of Cancer Epidemiology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

3Department of Integrated Mathematical Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

4Department of Internal Medicine, University of South Florida, Tampa, United States of America

5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, United States of America

6Department of Pathology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

7Department of Biostatistics and Bioinformatics, Moffitt Cancer Center and Research Institute, Tampa, United States of America

8Department of Radiation Oncology, Moffitt Cancer Center and Research Institute, Tampa, United States of America

Find articles by Gillis, N. in: PubMed | Google Scholar

Published June 9, 2026 - More info

J Clin Invest. https://doi.org/10.1172/JCI204429.
Copyright © 2026, Arabzadeh et al. This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
Published June 9, 2026 - Version history
View PDF
Abstract

Clonal hematopoiesis (CH) is the age-related expansion of mutated hematopoietic stem cells without hematologic abnormalities. In patients with solid tumors, CH is associated with higher mortality and may evolve to therapy-related myeloid neoplasms; however, the mechanisms by which cancer treatments promote CH dynamics remain largely unknown. Here, we analyzed 392 serial samples from a prospective cohort of breast cancer patients and showed that cytotoxic treatments led to strong therapeutic bottlenecks, resulting in significant reductions in hematopoietic allelic populations and differential clonal selection. Positively selected CH that expanded through dose-dependent therapeutic bottlenecks harbored mutations in TP53, PPM1D, SRCAP, DNMT3A, and YLPM1. Patients with positively selected CH during treatment had the shortest progression-free and overall survival compared to patients with unchanging or negatively selected CH across all therapies. These findings, validated in independent breast cancer and pan-cancer cohorts, provide strong evidence for clinical relevance of monitoring CH during cancer treatment.

Graphical Abstract
graphical abstract
Supplemental material

View

View Supplemental Tables

Version history
  • Version 1 (June 9, 2026): In-Press Preview

Article tools

  • View PDF
  • Download citation information
  • Send a comment
  • Terms of use
  • Standard abbreviations
  • Need help? Email the journal

Metrics

  • Article usage
  • Citations to this article

Go to

  • Top
  • Abstract
  • Supplemental material
  • Version history
Advertisement
Advertisement

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts